Beryl Drugs Limited
Nature of Disclosure: Regulatory filing pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying the Bombay Stock Exchange about an upcoming board meeting.
Meeting Details: The 06/2026-2027 Meeting of the Board of Directors is scheduled to be held on Saturday, 14th November, 2026 at 02:00 P.M. at the Registered Office of the company situated at 29, Neer Nagar, Mayank Water Park Road, Bicholi, Indore (M.P.) 452016.
Agenda Items: The Board will inter alia consider and approve the following matters along with other routine businesses:
- Unaudited Financial Results for the quarter ended 30th September, 2026 of the company
- Limited Review Report for the quarter ended 30th September, 2026 of the company
- Any other matter with the permission of chair
Trading Window Update: Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company, which was closed from 1st July 2026, will open after 48 hours from the conclusion of the Board Meeting to be held on 14th November, 2026.
Regulatory Reference: This disclosure is made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.